KIG
REGN icon

Kessler Investment Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Kessler Investment Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30
Closed -$15.8K – 175
2025
Q2 		$15.8K Hold
30
– – 0.01% 126
2025
Q1 		$19K Hold
30
– – 0.01% 126
2024
Q4 		$21.4K Hold
30
– – 0.01% 108
2024
Q3 		$31.5K Hold
30
– – 0.02% 105
2024
Q2 		$31.5K Hold
30
– – 0.02% 103
2024
Q1 		$28.9K Hold
30
– – 0.02% 98
2023
Q4 		$26.3K Hold
30
– – 0.02% 105
2023
Q3 		$24.7K Hold
30
– – 0.02% 92
2023
Q2 		$21.6K Hold
30
– – 0.02% 99
2023
Q1 		$24.6K Hold
30
– – 0.02% 108
2022
Q4 		$22K Hold
30
– – 0.02% 94
2022
Q3 		$21K Hold
30
– – 0.02% 111
2022
Q2 		$18K Sell
30
-30
-50% -$19.5K 0.02% 111
2022
Q1 		$42K Buy
+60
New +$38K 0.02% 107

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return